Epigallocatechin Gallate

CAS No. 989-51-5

Epigallocatechin Gallate ( EGCG )

Catalog No. M16903 CAS No. 989-51-5

Epigallocatechol Gallate(EGCG) is an antioxidant polyphenol flavonoid that inhibits telomerase and Dna methyltransferase.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 27 In Stock
50MG 39 In Stock
100MG 51 In Stock
500MG 124 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Epigallocatechin Gallate
  • Note
    Research use only, not for human use.
  • Brief Description
    Epigallocatechol Gallate(EGCG) is an antioxidant polyphenol flavonoid that inhibits telomerase and Dna methyltransferase.
  • Description
    Epigallocatechol Gallate(EGCG) is an antioxidant polyphenol flavonoid that inhibits telomerase and Dna methyltransferase. EGCG blocks the activation of EGF receptors and HER-2 receptors.
  • Synonyms
    EGCG
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    989-51-5
  • Formula Weight
    458.38
  • Molecular Formula
    C22H18O11
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 83 mg/mL warmed (181.07 mM); Water: 23 mg/mL warmed (50.17 mM); DMSO: 72 mg/mL warmed (157.07 mM)
  • SMILES
    O=C(O[C@H]1[C@@H](C2=CC(O)=C(O)C(O)=C2)OC3=C(C(O)=CC(O)=C3)C1)C4=CC(O)=C(O)C(O)=C4
  • Chemical Name
    [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Khan N, et al. Y Res, 2006, 66(5), 2500-2505.
molnova catalog
related products
  • Mini Gastrin I, huma...

    Mini Gastrin I, human (TFA) is short for human Gastrin. It is a mother peptide composed of 5-17 amino acids.

  • Nordihydrocapsaicin

    Nordihydrocapsaicin?is a capsaicinoid and analog and?congener?of?capsaicin?in?chili peppers?(Capsicum).

  • fulvotomentoside A

    Fulvotomentoside A could decrease overexpression of IL-6 and IL-17A, and increase the expression of specific transcription factor Foxp3 of regulatory T cells significantly in intestine.